Michael Chi - Sep 13, 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Commercial Officer
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Sep 13, 2024
Transactions value $
-$1,122,536
Form type
4
Date filed
9/17/2024, 07:07 PM
Previous filing
Aug 2, 2024
Next filing
Oct 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +76.5K +41.28% 262K Sep 13, 2024 Direct F1
transaction HIMS Class A Common Stock Tax liability -$701K -42.3K -16.16% $16.57 220K Sep 13, 2024 Direct
transaction HIMS Class A Common Stock Sale -$422K -25.6K -11.64% $16.50 194K Sep 17, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -15K -25% $0.00 45K Sep 13, 2024 Class A Common Stock 15K Direct F1, F3
transaction HIMS Restricted Stock Unit Options Exercise $0 -19.4K -6.67% $0.00 271K Sep 13, 2024 Class A Common Stock 19.4K Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -16.3K -9.09% $0.00 163K Sep 13, 2024 Class A Common Stock 16.3K Direct F1, F5
transaction HIMS Restricted Stock Unit Options Exercise $0 -9.36K -14.29% $0.00 56.1K Sep 13, 2024 Class A Common Stock 9.36K Direct F1, F6
transaction HIMS Restricted Stock Unit Options Exercise $0 -16.5K -11.11% $0.00 132K Sep 13, 2024 Class A Common Stock 16.5K Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024 by the Reporting Person.
F3 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on June 15, 2022, and the remaining 75% of the RSUs vesting insubstantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.
F4 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
F5 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.
F6 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.
F7 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2022.